Incidence of Visual Impairment Over a 20-Year Period The Beaver Dam Eye Study

被引:64
|
作者
Klein, Ronald [1 ]
Lee, Kristine E. [1 ]
Gangnon, Ronald E. [2 ,3 ]
Klein, Barbara E. K. [1 ]
机构
[1] Univ Wisconsin, Sch Med & Publ Hlth, Dept Ophthalmol & Visual Sci, Madison, WI 53726 USA
[2] Univ Wisconsin, Sch Med & Publ Hlth, Dept Biostat & Med Informat, Madison, WI 53726 USA
[3] Univ Wisconsin, Sch Med & Publ Hlth, Dept Populat Hlth Sci, Madison, WI 53726 USA
基金
美国国家卫生研究院;
关键词
AGE-RELATED MACULOPATHY; BLUE MOUNTAINS EYE; UNITED-STATES; MACULAR DEGENERATION; SOCIOECONOMIC-STATUS; POPULATION; PREVALENCE; ACUITY; BLINDNESS; AMERICANS;
D O I
10.1016/j.ophtha.2012.11.041
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To describe visual impairment (VI) over a 20-year period and its associations with age-related eye diseases and socioeconomic factors in the Beaver Dam Eye Study. Design: Population-based cohort study. Participants: Four thousand nine hundred twenty-six persons 43 to 86 years of age participated in the baseline examination phase from 1988 through 1990, and 3721, 2962, 2375, and 1913 persons participated in follow-up examinations each spaced 5 years apart from 1993 through 1995, 1998 through 2000, 2003 through 2005, and 2008 through 2010, respectively. Methods: Best-corrected visual acuity after refraction, assessed by the Early Treatment Diabetic Retinopathy Study protocol. Main Outcome Measures: Incidence of VI, defined as best-corrected visual acuity of poorer than 20/40 in the better eye in persons with one or both eyes 20/40 or better at the beginning of a 5-year interval, and incidence of severe VI, defined as best-corrected visual acuity of 20/200 or worse in the better eye in persons with one or both eyes better than 20/200 at the beginning of a 5-year interval. Results: Overall incidence of VI between examinations (5-year interval) was 1.4% (varying from 0.1% in persons 50-54 years of age to 14.6% in those 85 years of age and older), whereas for severe VI it was 0.4% (varying from 0.0% in persons 50-54 years of age to 6.9% in those >= 85 years of age). The incidence of VI decreased for each period after adjustment for age, from the first 5-year interval between examinations (1988-1990 to 1993-1995) to the fourth and most recent 5-year interval (2003-2005 to 2008-2010; odds ratio fourth interval vs. first interval, 0.53; 95% confidence interval, 0.32-0.87; P = 0.01). This period effect was no longer significant after adjustment for age-related macular degeneration. Age-related macular degeneration remained the leading cause of incident severe VI (54% of eyes with incident severe VI, which was as low as 40% and as high as 57% for specific visits), with no evidence of a trend across visits. The overall frequency of VI correctable with new refraction was 38% of all eyes with VI. Conclusions: These data provide population-based estimates that show a high (15%) 5-year incidence of VI in persons 85 years of age and older. Age-related macular degeneration remained the leading cause of severe VI in this population over the 20 years of the study. (C) 2013 by the American Academy of Ophthalmology.
引用
收藏
页码:1210 / 1219
页数:10
相关论文
共 50 条
  • [1] Refraction and Change in Refraction Over a 20-Year Period in the Beaver Dam Eye Study
    Bomotti, Samantha
    Lau, Bryan
    Klein, Barbara E. K.
    Lee, Kristine E.
    Klein, Ronald
    Duggal, Priya
    Klein, Alison P.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (11) : 4518 - 4524
  • [2] Relation of Smoking, Drinking, and Physical Activity to Changes in Vision over a 20-Year Period The Beaver Dam Eye Study
    Klein, Ronald
    Lee, Kristine E.
    Gangnon, Ronald E.
    Klein, Barbara E. K.
    OPHTHALMOLOGY, 2014, 121 (06) : 1220 - 1228
  • [3] Changing Incidence of Lens Extraction over 20 Years The Beaver Dam Eye Study
    Klein, Barbara E. K.
    Howard, Kerri P.
    Lee, Kristine E.
    Klein, Ronald
    OPHTHALMOLOGY, 2014, 121 (01) : 5 - 9
  • [4] Five-year incidence of visual impairment and blindness in older Icelanders: the Reykjavik Eye Study
    Gunnlaugsdottir, Elin
    Arnarsson, Arsaell
    Jonasson, Fridbert
    ACTA OPHTHALMOLOGICA, 2010, 88 (03) : 358 - 366
  • [5] Five-Year Incidence of Visual Impairment in Middle-Aged Iranians: The Shahroud Eye Cohort Study
    Hashemi, Hassan
    Mehravaran, Shiva
    Emamian, Mohammad Hassan
    Fotouhi, Akbar
    OPHTHALMIC EPIDEMIOLOGY, 2017, 24 (01) : 11 - 16
  • [6] Five-Year Incidence of Visual Impairment and Blindness in Adult Chinese The Beijing Eye Study
    You, Qi Sheng
    Xu, Liang
    Yang, Hua
    Wang, Ya Xing
    Jonas, Jost B.
    OPHTHALMOLOGY, 2011, 118 (06) : 1069 - 1075
  • [7] Six-Year Incidence of Blindness and Visual Impairment in Kenya: The Nakuru Eye Disease Cohort Study
    Bastawrous, Andrew
    Mathenge, Wanjiku
    Wing, Kevin
    Rono, Hillary
    Gichangi, Michael
    Weiss, Helen A.
    Macleod, David
    Foster, Allen
    Burton, Matthew J.
    Kuper, Hannah
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (14) : 5974 - 5983
  • [8] Markers of Inflammation, Oxidative Stress, and Endothelial Dysfunction and the 20-Year Cumulative Incidence of Early Age-Related Macular Degeneration The Beaver Dam Eye Study
    Klein, Ronald
    Myers, Chelsea E.
    Cruickshanks, Karen J.
    Gangnon, Ronald E.
    Danforth, Lorraine G.
    Sivakumaran, Theru A.
    Iyengar, Sudha K.
    Tsai, Michael Y.
    Klein, Barbara E. K.
    JAMA OPHTHALMOLOGY, 2014, 132 (04) : 446 - 455
  • [9] Four-Year Incidence and Progression of Visual Impairment in Latinos: The Los Angeles Latino Eye Study
    Varma, Rohit
    Chung, Jessica
    Foong, Athena W. P.
    Torres, Mina
    Choudhury, Farzana
    Azen, Stanley P.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2010, 149 (05) : 713 - 727
  • [10] Danish Rural Eye Study: Epidemiology of Adult Visual Impairment
    Hoeg, Tracy Beth
    Ellervik, Christina
    Buch, Helena
    La Cour, Morten
    Klemp, Kristian
    Kvetny, Jan
    Erngaard, Ditte
    Moldow, Birgitte
    OPHTHALMIC EPIDEMIOLOGY, 2016, 23 (01) : 53 - 62